Envetec and Enva Agree Collaboration to Advance a Circular Economy for Biohazardous Waste Materials in Ireland & the UK
This process emits huge amounts of CO2 and other greenhouse gases, uses vast amounts of water and is incredibly damaging to the environment. According pin up online casino to Health Care Without Harm, the healthcare sector alone contributes 4.4% of global emissions, and that footprint is forecast to triple by 2050. Healthcare and life science organizations can now recycle biohazardous materials that were previously impossible to recycle.
This decarbonisation plan is in line with the Irish Government’s Climate Action Plan 2021 (Irish Government, 2021). Imogen spent her executive career in the fintech arena as Commercial Director of the London Stock Exchange and latterly President of two divisions of S&P Global. She brings global experience to the boards that she serves plus a strong commercial, client and talent-focused agenda while specialising in Remuneration Committee work on both listed and non-listed boards. While the mishandling or improper disposal of biohazardous waste can lead to the spread of foodborne illnesses and environmental contamination, the impact of traditional disposal methods on the environment is also extremely detrimental. GENERATIONS is helping the largest private hospital group in New York State treat their regulated medical waste sustainably and can also help your healthcare facility to achieve its sustainability goals. He established W2 over 25 years ago, creating a group of businesses that support marketing & strategic planning, leadership development, client acquisition.
Envetec and Enva Agree Collaboration to Advance a Circular Economy for Biohazardous Waste Materials in Ireland & the UK
The transition to more sustainable biohazardous waste management practices in the Food & Beverage industry not only aligns with environmental objectives but also presents economic opportunities. By doing so, Veterinary care facilities can lower their emissions related to waste by up to 90%. The veterinary science industry’s commitment to sustainability aligns with global initiatives aimed at reducing the carbon footprint of industrial operations and promoting a circular economy. For instance, the European Union’s Farm to Fork Strategy (2020) emphasizes the importance of sustainable food production systems, including responsible waste management practices along the entire supply chain.
Food & Beverage
Ironically it is the very environment where animals inhabit that ultimately gets affected by climate change.Large veterinary care providers, small clinics and laboratories have committed to obtaining Net Zero status, many with ambitiously accelerated timelines. A key component of reaching Net Zero is to address the huge amount of waste that is produced by the Veterinary sector, particularly biohazardous waste (also referred to as Regulated Waste (RMW)). By eliminating high-carbon transportation and thermal treatments, GENERATIONS enables medical technology facilities to recycle waste that would otherwise end up in landfills. This innovative solution empowers the industry to significantly reduce its emissions and contribute to a more sustainable future. These actions are in line with the Health Service Executive (HSE) in Ireland, a public healthcare body, decarbonisation plans to become net zero energy related emissions by 2050 (HSE Infrastructure Decarbonisation Roadmap, 2021).
W2 is a blend of his experience in international sport, broadcasting and business, built on an understanding of success and failure in high performing teams and individuals. Investor wise, Keith has followed his interests, from media to property, from sports science to rural regeneration, from healthy ageing to lifestyle businesses.Keith captained the Irish Rugby Team 36 times, toured with the Lions twice, and is the inaugural winner of the World Player of the Year in 2001. Keith has worked extensively in journalism and media, writing for The Times, The Daily Telegraph, and Independent News as well as broadcasting for the BBC and Newstalk.
Malcolm Bell
Extended life expectancy as well as improving quality of life has been the direct result of improved therapeutics in almost all facets of life. Envetec GENERATIONS is an on-site, non-thermal, Clean Technology that treats biohazardous waste onsite in a quick, effective and sustainable way. Mr Kenny (71), who was taoiseach from 2011 to 2017, is one of five recent appointments to the board of the cleantech business, which has raised €10 million in new funding to support its growth. Mr Kenny has secured a number of directorships since stepping down as taoiseach, including with Heneghan, the Ireland China Institute and Carbon Collect Ltd.
National and International health systems have publicly acknowledged this threat and have taken responsibility by committing to reaching carbon net zero, in response to the profound and growing threat to health posed by climate change. A key component of reaching Net Zero is to address the huge amount of waste that is produced by the healthcare sector, particularly biohazardous waste (also referred to as Regulated Medical Waste (RMW)). The Food & Beverage industry’s commitment to sustainability aligns with global initiatives aimed at reducing the carbon footprint of industrial operations and promoting a circular economy. For instance, the United Nations’ Sustainable Development Goals (SDGs) emphasize the importance of sustainable food production systems and responsible consumption and production patterns. Paul gained his BSC from UCD and moved from University to roles covering both Laboratory and QA with the Kerry Group.
- The other board members are Michael Dowling, president and chief executive of Northwell Health; Eva Pisa, a former senior vice-president of Roche Diagnostics; Imogen Joss, former president of S&P Global Market Intelligence and Platts, and now chair of Grant Thornton UK; and James Connelly, chief executive of My Green Lab.
- These frameworks aim to ensure the safe and responsible handling, treatment, and disposal of biohazardous materials, safeguarding both human and animal health while minimizing environmental impacts.
- Traditional methods like incineration are energy-intensive, highlighting the need for sustainable solutions.
- Because of the novel nature of this process treated waste can be diverted from incineration and landfill as GENERATIONS act as an essential link in the chain for recycling of biohazardous waste.
We create clean change by eliminating the existing harmful treatment and disposal of laboratory biohazardous waste.
Keith is an Honorary Fellow Of the Royal College of Surgeons for his Role as Chair of the Healthy Ireland Council and holds an Honorary Doctor of Science from UL for services to Sport and Community. In addition, he is a Patron of both the Special Olympics and the UNESCO Chair for Inclusive Physical Education, Sport, Recreation, and Fitness in Tralee IT. Biohazardous waste in the veterinary context encompasses a wide range of materials, including infectious substances, sharps, pathological waste, and animal carcasses. The mishandling or improper disposal of these materials can lead to the spread of zoonotic diseases, environmental contamination, and the release of harmful pathogens into the ecosystem.
Healthcare
Malcolm Bell serves as Chief Executive Officer of Envetec Sustainable Technologies, Ireland’s first cleantech company focused on breakthrough innovations to treat and repurpose biohazardous waste materials on-site, significantly reducing dependency on landfills, incineration and autoclaving. Addressing the growing urgency to achieve a substantive path toward net-zero from the diagnostic, healthcare, and food and beverage industries, Malcolm established Envetec as a standalone business in 2021. He served as CEO and oversaw the successful acquisition of the company to LGC in 2020.Malcolm has a track record of creating significant value by advancing assets, intellectual property, technology, and product portfolios.
By doing so, Food and Beverage facilities can lower their emissions related to waste by up to 90%. Furthermore, individual countries are implementing ambitious decarbonization plans that directly impact the pharmaceutical industry. In the United Kingdom, the National Health Service (NHS) has set a goal of achieving net-zero emissions by 2040, with a particular focus on reducing single-use plastics and improving waste management practices. The NHS’s “Clinical Waste Strategy” specifically calls for the adoption of innovative technologies to enable on-site treatment of biohazardous waste, reducing the need for transportation and off-site incineration. Peter brings significant experience in corporate finance, business development and financial management in both public and private life science companies. Peter is a non-executive director of Avadel Pharmaceuticals plc, a NASDAQ listed biopharmaceutical company, and Oculer Limited, a company developing and commercialising proprietary rapid microbiology technology.
- By integrating GENERATIONS into their waste management practices, pharmaceutical companies can lead the way towards a sustainable future, safeguarding the environment and enhancing long-term business resilience.
- PH balanced effluent is sent to the GENERATIONS filtration unit where it is filtered removing any visible solids and microplastics.
- While the mishandling or improper disposal of biohazardous waste can lead to the spread of foodborne illnesses and environmental contamination, the impact of traditional disposal methods on the environment is also extremely detrimental.
- The medical technology industry plays a vital role in healthcare, but its operations can contribute significantly to the climate crisis.
- By aligning the environmental interests of the planet, with the economic interest of the stakeholders, the sustainability effort can itself, become sustainable.
As pharmaceutical facilities prioritize sustainability, the adoption of disruptive technologies like our GENERATIONS system becomes essential. GENERATIONS offers an innovative solution for treating biohazardous waste on-site, reducing transportation needs and eliminating off-site incineration. This approach not only cuts greenhouse gas emissions and air pollution but also promotes resource efficiency by recovering valuable materials from waste streams.
GENERATIONS breakthrough technology safely and effectively treats biohazardous waste material onsite, including plastics, glass, PPE, sharps containers, and other general laboratory consumables. Healthcare and life science organisations can now recycle biohazardous materials that were previously impossible to recycle. “We have identified five outstanding independent directors who have the right mix of leadership skills and experience underscored by a genuine, collective passion for advancing best-in-class technologies that benefit the environment and the economy,” said Malcolm Bell, chairman and chief executive of Envetec. Because of the novel nature of this process treated waste can be diverted from incineration and landfill as GENERATIONS act as an essential link in the chain for recycling of biohazardous waste. The other board members are Michael Dowling, president and chief executive of Northwell Health; Eva Pisa, a former senior vice-president of Roche Diagnostics; Imogen Joss, former president of S&P Global Market Intelligence and Platts, and now chair of Grant Thornton UK; and James Connelly, chief executive of My Green Lab. There is a growing international call for a new disruptive technology that would work effectively and be economically beneficial at the same time.
In 2014, he spun out two companies from Technopath – ValitaCell Ltd and Oculer Ltd, respectively. Within 12 months, he created a five-year strategic roadmap to support critical funding initiatives, including evaluating the Health System’s existing investment portfolio, investment companies, and joint ventures alongside introducing a new operating model and organizational structure. Malcolm earned his undergraduate degree in molecular biology and his master’s degree in biotechnology from the National University of Ireland. The transition to more sustainable biohazardous waste management practices in the veterinary science industry not only aligns with environmental objectives but also presents economic opportunities. By embracing innovative technologies that enable the recovery and reuse of valuable materials from waste streams, facilities can realize cost savings, improve resource efficiency, and contribute to the development of a circular economy.
| No. | Currency | BUYING RATE | SELLING RATE |
|---|---|---|---|
| 1 | USD | ||
| 2 | GBP | ||
| 3 | EUR | ||
| 4 | AED | ||
| 5 | AUD | ||
| 6 | CAD | ||
| 7 | JPY | ||
| 8 | SAR |
